Adverse Events in Randomized Trials Neglected, Restricted, Distorted, and Silenced

被引：182

作者：

Ioannidis, John P. A. ^{[1
]}

机构：

[1] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece

来源：

ARCHIVES OF INTERNAL MEDICINE | 2009年 / 169卷 / 19期

关键词：

CARDIOVASCULAR EVENTS; CLINICAL-TRIALS; METAANALYSIS; HARMS;

D O I：

10.1001/archinternmed.2009.313

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1737 / 1739

页数：3

共 10 条

[1] Composite Outcomes Can Distort the Nature and Magnitude of Treatment Benefits in Clinical Trials
Ferreira-Gonzalez, Ignacio
Permanyer-Miralda, Gaieta
Busse, Jason W.
Devereaux, P. J.
Guyatt, Gordon H.
Alonso-Coello, Pablo
Montori, Victor M.
[J]. ANNALS OF INTERNAL MEDICINE, 2009, 150 (08) : 566 - 567
[2] Challenges in meta-analysis of randomized clinical trials for rare harmful cardiovascular events: The case of rosiglitazone
Hernandez, Adrian V.
Walker, Esteban
Ioannidis, John P. A.
Kattan, Michael W.
[J]. AMERICAN HEART JOURNAL, 2008, 156 (01) : 23 - 30
[3] Why most published research findings are false
Ioannidis, JPA
[J]. PLOS MEDICINE, 2005, 2 (08) : 696 - 701
[4] Better reporting of harms in randomized trials: An extension of the CONSORT statement
Ioannidis, JPA
Evans, SJW
Gotzsche, PC
O'Neill, RT
Altman, DG
Schulz, K
Moher, D
[J]. ANNALS OF INTERNAL MEDICINE, 2004, 141 (10) : 781 - 788
[5] Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Juni, P
Nartey, L
Reichenbach, S
Sterchi, R
Dieppe, PA
Egger, M
[J]. LANCET, 2004, 364 (9450) : 2021 - 2029
[6] The Neurontin legacy - Marketing through Misinformation and Manipulation
Landefeld, C. Seth
Steinman, Michael A.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (02) : 103 - 106
[7] Dealing with a deluge of data: An assessment of adverse event data on North Central Cancer Treatment Group trials
Mahoney, MR
Sargent, DJ
O'Connell, MJ
Goldberg, RM
Schaefer, P
Buckner, JC
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (36) : 9275 - 9281
[8] Comparison of evidence on harms of medical interventions in randomized and nonrandomized studies
Papanikolaou, PN
Christidi, GD
Ioannidis, JPA
[J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2006, 174 (05) : 635 - 641
[9] Reporting of Safety Results in Published Reports of Randomized Controlled Trials
Pitrou, Isabelle
Boutron, Isabelle
Ahmad, Nizar
Ravaud, Philippe
[J]. ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (19) : 1756 - +
[10] Inadequate statistical power to detect clinically significant differences in adverse event rates in randomized controlled trials
Tsang, Ruth
Colley, Lindsey
Lynd, Larry D.
[J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2009, 62 (06) : 609 - 616

← 1 →